Letters to the Editor

Antipruritic Effect of Oral Cyclosporin A in Essential Senile Pruritus
Sir, RESULTS Ten patients, aged between 59 and 72 years (6 women and 4 men), affected with essential pruritus were enrolled in the All 10 subjects completed the study. The status of pruritus study after verbal informed consent was obtained. At clinical was assessed and compared with the baseline using the VAS investigation all patients presented with discomforting diffuse forms filled in by patients at each visit. CyA treatment pruritus of 6 to 11 months' duration and which frequently significantly reduced the itch intensity in all 10 patients. Four disturbed sleep at night. None of the subjects presented any patients experienced an improvement of pruritus within a few specific skin alterations and all were resistant to oral antidays. Six others showed a decrease in itch on days 10-12. A histamines, topical and systemic corticosteroids and topical total of eight subjects were free of pruritus within the 4th emollients.
week of treatment, but two subjects who had experienced consistent itch relief by the 14th day of CyA treatment had no further improvement. At the clinical follow-up no relapse MATERIAL AND METHODS were reported until 3 months after discontinuation of therapy.
Study design
One subject referred a mild localized pruritus 1 month after This open uncontrolled study was designed for subjects with persistent discontinuation of therapy.
pruritus for a minimum of 6 months before entry into the study.
None of the patients enrolled had significant adverse reac- Neoral, Sandoz) 5 mg/kg/day in two administrations for 8 weeks. The initial dose was maintained for 4 weeks and then gradually reduced by 0.5 mg/kg/day every week until discontinuation of the therapy.
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